Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 2008

View Archived Issues

HSPA12B, a novel target for antiangiogenesis therapy

Novel monoclonal antibodies show low tendency for bleeding in models of arterial thrombosis

Titan presents positive phase III results for Probuphine in opioid addiction

FDA grants orphan drug designation to Polyphenon's Polyphenon E for CLL

Allergan to initiate phase I clinical development of retargeted endopeptidase drug candidate

CHMP recommends refusal of Santhera's MAA for Sovrima in Friedreich's ataxia

FDA issues not approvable letter in response to Vanda's NDA for iloperidone in schizophrenia

Anticoagulant Xarelto recommended for approval in E.U.; NDA submitted in U.S.

Chinese SFDA approves Nexavar for HCC

No improvement with BioBypass gene therapy in patients with refractory ischemia

A Ginkgo biloba extract improves cognitive and neuropsychiatric symptoms in AD and vascular dementia

Clinical results with bapineuzumab immunotherapy in mild to moderate AD reported at ICAD

GPC Biotech reports withdrawal of MAA for satraplatin in prostate cancer

FDA issues not approvable letter to Eisai for sedative-hypnotic agent fospropofol disodium

SuperArray Bioscience changes name to SABiosciences

Merck & Co places development hold on HIV protease inhibitor PPL-100

CHMP recommends marketing authorization for GSK's prepandemic influenza vaccine

Sanofi pasteur agrees terms of cash offer for share capital of Acambis

Arpida submits MAA to the EMEA for iclaprim in cSSTI

Roche submits application to EMEA to extend label for Avastin in breast cancer

MediGene's Oracea receives marketing authorization in Europe

Nuvelo commences phase I NU-206 trial in healthy volunteers

European Commission approves Schering-Plough's Bridion

Novel antidiabetic agents claimed in recent patents

Advances in development of agents for neurological disorders documented in recent patents

FDA issues not approvable letter to UCB for Vimpat in diabetic neuropathic pain

Novel Rho kinase inhibitors developed at sanofi-aventis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...